Aristeia Capital L.L.C. Invests $355,000 in Pediatrix Medical Group, Inc. $MD

Key Points

• Aristeia Capital L.L.C. has acquired 24,475 shares of Pediatrix Medical Group, Inc., valued at approximately $355,000, marking a new stake during the first quarter.
• Several other institutional investors have also either increased or initiated stakes in Pediatrix Medical Group, resulting in hedge funds and institutional investors owning 97.71% of the company's stock.
• Pediatrix Medical Group reported an earnings per share (EPS) of $0.53 for the last quarter, exceeding analyst expectations, although revenue declined by 7.1% compared to the previous year.

Aristeia Capital L.L.C. bought a new position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 24,475 shares of the company's stock, valued at approximately $355,000.

A number of other large investors have also added to or reduced their stakes in the company. Boston Partners raised its holdings in Pediatrix Medical Group by 1.3% in the first quarter. Boston Partners now owns 1,981,889 shares of the company's stock worth $27,990,000 after purchasing an additional 25,536 shares in the last quarter. Northern Trust Corp raised its holdings in Pediatrix Medical Group by 18.0% in the fourth quarter. Northern Trust Corp now owns 966,347 shares of the company's stock worth $12,678,000 after purchasing an additional 147,522 shares in the last quarter. Invesco Ltd. raised its holdings in Pediatrix Medical Group by 9.3% in the first quarter. Invesco Ltd. now owns 863,269 shares of the company's stock worth $12,509,000 after purchasing an additional 73,157 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Pediatrix Medical Group by 6.2% in the first quarter. Principal Financial Group Inc. now owns 586,190 shares of the company's stock worth $8,494,000 after purchasing an additional 34,266 shares in the last quarter. Finally, Bridgeway Capital Management LLC increased its holdings in shares of Pediatrix Medical Group by 1.7% during the first quarter. Bridgeway Capital Management LLC now owns 554,452 shares of the company's stock valued at $8,034,000 after acquiring an additional 9,007 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Wall Street Zen downgraded shares of Pediatrix Medical Group from a "strong-buy" rating to a "buy" rating in a report on Saturday. UBS Group upped their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a report on Thursday, August 14th. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. Finally, Leerink Partners upped their price objective on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the company a "market perform" rating in a report on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group has an average rating of "Moderate Buy" and a consensus target price of $16.79.

Pediatrix Medical Group Stock Performance

NYSE:MD traded down $0.34 during midday trading on Friday, hitting $16.67. The company's stock had a trading volume of 524,924 shares, compared to its average volume of 774,244. Pediatrix Medical Group, Inc. has a fifty-two week low of $10.39 and a fifty-two week high of $17.67. The firm's 50 day moving average is $14.75 and its 200-day moving average is $14.18. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80. The firm has a market cap of $1.45 billion, a P/E ratio of 12.92 and a beta of 1.30.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company had revenue of $468.84 million for the quarter, compared to the consensus estimate of $464.37 million. During the same quarter in the prior year, the company earned $0.34 EPS. Pediatrix Medical Group's quarterly revenue was down 7.1% on a year-over-year basis. Equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.